Martyn Caplin

28.4k total citations · 7 hit papers
293 papers, 16.0k citations indexed

About

Martyn Caplin is a scholar working on Epidemiology, Oncology and Neurology. According to data from OpenAlex, Martyn Caplin has authored 293 papers receiving a total of 16.0k indexed citations (citations by other indexed papers that have themselves been cited), including 264 papers in Epidemiology, 214 papers in Oncology and 178 papers in Neurology. Recurrent topics in Martyn Caplin's work include Neuroendocrine Tumor Research Advances (261 papers), Lung Cancer Research Studies (178 papers) and Neuroblastoma Research and Treatments (174 papers). Martyn Caplin is often cited by papers focused on Neuroendocrine Tumor Research Advances (261 papers), Lung Cancer Research Studies (178 papers) and Neuroblastoma Research and Treatments (174 papers). Martyn Caplin collaborates with scholars based in United Kingdom, Germany and United States. Martyn Caplin's co-authors include Christos Toumpanakis, Guido Rindi, Philippe Ruszniewski, Wouter W. de Herder, Robert T. Jensen, Jamshed Bomanji, Bertram Wiedenmann, Ola Nilsson, Jaume Capdevila and Joseph Davar and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Martyn Caplin

279 papers receiving 15.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors

2014 1.3k citations Martyn Caplin, Marianne Pavel et al. profile →
Gastroenteropancreatic neuroendocrine tumours

2008 1.2k citations Kjell Öberg, Robert T. Jensen et al. profile →
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system

2006 1.2k citations Martyn Caplin, Wouter W. de Herder et al. profile →
ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors

2016 911 citations Massimo Falconi, Barbro Eriksson et al. Neuroendocrinology profile →
ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas

2016 403 citations Rocio García‐Carbonero, Halfdan Sørbye et al. Neuroendocrinology profile →
Recommendations for management of patients with neuroendocrine liver metastases

2014 349 citations Martyn Caplin et al. profile →
Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With ¹⁷⁷Lu-Dotatate in the Phase III NETTER-1 Trial

2018 272 citations Matthew H. Kulke, Martyn Caplin et al. profile →

Peers

Countries citing papers authored by Martyn Caplin

Since Specialization

Citations

This map shows the geographic impact of Martyn Caplin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martyn Caplin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martyn Caplin more than expected).

Fields of papers citing papers by Martyn Caplin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martyn Caplin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martyn Caplin. The network helps show where Martyn Caplin may publish in the future.

Co-authorship network of co-authors of Martyn Caplin

This figure shows the co-authorship network connecting the top 25 collaborators of Martyn Caplin. A scholar is included among the top collaborators of Martyn Caplin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martyn Caplin. Martyn Caplin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neuroendocrine tumours and pregnancy: Real‐world data from an European Neuroendocrine Tumour Centre of Excellence 2024 ·Journal of Neuroendocrinology ·(unknown), (unknown), Thomas Glover, (unknown), Aimee R. Hayes, (unknown), Dalvinder Mandair, Bernard Khoo, Tu Vinh Luong, Christos Toumpanakis, Ashley Grossman, Martyn Caplin	0
2	PREF-NET: a patient preference and experience study of lanreotide autogel administered in the home versus hospital setting among patients with gastroenteropancreatic neuroendocrine tumours in the UK 2024 ·Supportive Care in Cancer ·Mohid S. Khan, Kathryn Cook, Martin O. Weickert, Louise Davies, D. Mark Pritchard, Melissa A. Day, Tahir Shah, Diana Hull, Martyn Caplin, (unknown), (unknown), (unknown)	2
3	The impact of COVID‐19 on the management of neuroendocrine tumors (NETS): An international NET CONNECT survey of NET patients and healthcare professionals treating net patients 2022 ·Journal of Neuroendocrinology ·Mauro Cives, Jorge Hernando, Ángela Lamarca, Catherine Bouvier, Martyn Caplin, Marianne Pavel	2
4	Treatment of neuroendocrine tumours with ¹⁷⁷ Lu‐peptide receptor radionuclide therapy: Challenging clinical scenarios and their management 2022 ·Journal of Neuroendocrinology ·Shaunak Navalkissoor, Christos Toumpanakis, Martyn Caplin, Gopinath Gnanasegaran	4
5	Single centre retrospective review of outcome of ¹⁷⁷ Lu‐DOTATATE peptide receptor radionuclide therapy in the treatment of progressive metastatic neuroendocrine tumours: Survival, toxicity, and prognostic factors 2022 ·Journal of Neuroendocrinology ·(unknown), Gopinath Gnanasegaran, (unknown), Ann‐Marie Quigley, Dalvinder Mandair, Christos Toumpanakis, Martyn Caplin, Shaunak Navalkissoor	5
6	ENETS standardized (synoptic) reporting for endoscopy in neuroendocrine tumors 2022 ·Journal of Neuroendocrinology ·Ivan Borbath, Ulrich‐Frank Pape, Pierre H. Deprez, Detlef K. Bartsch, Martyn Caplin, Massimo Falconi, Rocio García‐Carbonero, Simona Grozinsky‐Glasberg, Robert T. Jensen, Rudolf Arnold, Philippe Ruszniewski, Christos Toumpanakis, Juan W. Valle, Dermot O’Toole, (unknown)	13
7	Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors 2022 ·Clinical Cancer Research ·(unknown), Yien Ning Sophia Wong, (unknown), Ayse U. Akarca, Pawan Dhami, (unknown), Lucía Conde, Javier Herrero, Olagunju Ogunbiyi, Amir Gander, Tu Vinh Luong, (unknown), Martyn Caplin, Christos Toumpanakis, Karl S. Peggs, Sergio A. Quezada, Teresa Marafioti, Tim Meyer	7
8	Middle ear neuroendocrine tumours: Insight into their pathogenesis, diagnosis and management 2021 ·Journal of Neuroendocrinology ·(unknown), Tu Vinh Luong, Christos Toumpanakis, Martyn Caplin, Ashley Grossman	3
9	ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Chemotherapy 2017 ·Neuroendocrinology ·Rocio García‐Carbonero, Anja Rinke, Juan W. Valle, Nicola Fazio, Martyn Caplin, Vera Gorbounova, Juan Manuel O’Connor, Barbro Eriksson, Halfdan Sørbye, Matthew H. Kulke, Jie Chen, Jenny Falkerby, Frederico Costa, Wouter W. de Herder, Catherine Lombard‐Bohas, (unknown), (unknown)	82
10	ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors 2017 ·Neuroendocrinology ·Gregory Kaltsas, Martyn Caplin, Philippa Davies, Diego Ferone, Rocio García‐Carbonero, Simona Grozinsky‐Glasberg, Dieter Hörsch, Eva Tiensuu Janson, Réza Kianmanesh, Beata Kos‐Kudła, Marianne Pavel, Anja Rinke, Massimo Falconi, Wouter W. de Herder, (unknown)	99
11	ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents 2017 ·Neuroendocrinology ·Marianne Pavel, Juan W. Valle, Barbro Eriksson, Anja Rinke, Martyn Caplin, Jie Chen, Frederico Costa, Jenny Falkerby, Nicola Fazio, Vera Gorbounova, Wouter W. de Herder, Matthew H. Kulke, Catherine Lombard‐Bohas, Juan Manuel O’Connor, Halfdan Sørbye, Rocio García‐Carbonero, (unknown)	110
12	ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas breakdown → 2016 ·Neuroendocrinology ·Rocio García‐Carbonero, Halfdan Sørbye, Éric Baudin, Éric Raymond, Bertram Wiedenmann, Bruno Niederle, Eva Sedláčková, Christos Toumpanakis, Martin Anlauf, Jarosław B. Ćwikła, Martyn Caplin, Dermot O’Toole, Aurel Perren, (unknown)	403
13	Patient Interviews in TELESTAR, a Phase 3 Study of Telotristat Etiprate, Report Meaningful Improvement in Carcinoid Syndrome 2016 ·Neuroendocrinology ·(unknown), Dieter Hoersch, (unknown), (unknown), Michael Kulke, Emily K. Bergsland, Martyn Caplin, Kjell Öberg, Robert R. Warner, (unknown), (unknown), Janice L. Pasieka, Nick Pavlakis, Dana DiBenedetti, Pablo Lapuerta	1
14	Telotristat etiprate shows benefit in treating patients With carcinoid syndrome that is inadequately controlled by somatostatin analog therapy in the phase 3 TELESTAR clinical trial 2016 ·Pancreas ·Matthew H. Kulke, Dieter Hoersch, Martyn Caplin, Lowell Anthony, Emily K. Bergsland, Kjell Öberg, Staffan Welin, Richard R.P. Warner, Catherine Lombard‐Bohas, Pamela L. Kunz, Enrique Grande, Juan W. Valle, Douglas Fleming, Pablo Lapuerta, Phillip Banks, Shanna Jackson, (unknown), Brian Zambrowicz, Arthur Sands, Marianne Pavel	1
15	Early Changes in Circulating Tumor Cells Are Associated with Response and Survival Following Treatment of Metastatic Neuroendocrine Neoplasms 2015 ·Clinical Cancer Research ·Mohid S. Khan, Amy A. Kirkwood, Theodora Tsigani, Helen L. Lowe, Robert M. Goldstein, John A. Hartley, Martyn Caplin, Tim Meyer	66
16	Circulating Tumor Cells and EpCAM Expression in Neuroendocrine Tumors 2011 ·Clinical Cancer Research ·Mohid S. Khan, Theodora Tsigani, Mohammed Rashid, (unknown), Dominic Yu, Tu Vinh Luong, Martyn Caplin, Tim Meyer	90
17	Circulating Tumor Cells (CTCs) Correlate with Overall Survival in Neuroendocrine Tumors (NETs) 2011 ·UCL Discovery (University College London) ·Khan, Theodora Tsigani, Jorge García-Hernández, Martyn Caplin, Tim Meyer	1
18	Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study 2009 ·Endocrine Related Cancer ·Alia Ahmed, G. Turner, Barbara King, Louise Jones, David Culliford, David R. McCance, J. Ardill, Brian Johnston, G.J. Poston, M. Rees, M. Buxton‐Thomas, Martyn Caplin, John Ramage	215
19	Molecular Genetics of Gastroenteropancreatic Neuroendocrine Tumors 2008 ·The American Journal of Gastroenterology ·Christos Toumpanakis, Martyn Caplin	41
20	Use of Stents in the Palliative Treatment of Malignant Gastric Outlet and Duodenal Obstruction 2002 ·Clinical Radiology ·Ricardo Aviv, (unknown), (unknown), Anthony Watkinson, Jonathan Tibballs, Martyn Caplin, (unknown)	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact